Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3168738 | Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology | 2008 | 10 Pages |
Abstract
Alzheimer disease (AD) is a progressive neurologic disorder that manifests as memory loss, personality changes, global cognitive dysfunction, and functional impairment. As the United States population continues to age, the prevalence of AD will rise. Accordingly, oral health care providers will be more likely to treat patients affected by this disease; therefore, it is necessary to understand the pharmacologic agents used for the management of AD. This article provides an update of the available drug therapies for AD and discusses their implications on the oral and dental health of patients.
Related Topics
Health Sciences
Medicine and Dentistry
Dentistry, Oral Surgery and Medicine
Authors
Lena N. Turner, Ramesh Balasubramaniam, Elliot V. Hersh, Eric T. Stoopler,